Moderna plans to issue $2 billion in convertible senior notes with an option for an additional $300 million, with proceeds for general corporate purposes and capped call transactions.
FirstSquawk08/27, 06:25 PM
Related assets
Coming up for MRNA
Explore next
ZeroHedge08/27, 06:23 PM